Glimpse Vision is excited to offer Stellest – the first FDA authorized prescription lenses designed to slow myopia progression in children. Myopia, often referred to as nearsightedness, is predicted to affect 50% of the world’s population by 2050. The younger a child is when they become myopic, the faster their myopia tends to progress. We now have an option to correct your child’s nearsightedness as well as slow its progression over time.
Stellest lenses by Essilor:
- Slows myopia progression
- Corrects nearsightedness (Myopia)
- Are easy and comfortable to use
Stellest has proven to slow myopia progression by 71% on average over 2 years of consistent wear.*
Our experts can work with you and your child to select the perfect frame to maximize the effectiveness of this new technology.
How do Stellest lenses work?
Although myopia can be genetic, environmental factors such as spending less time outside and more time reading and prolonged device use play a significant role in development of nearsightedness. Stellest utilizes patented H.A.L.T technology to create a large single vision zone combined with highly aspherical lenslets. This provides great vision and comfort while slowing the elongation of the eye.
Why is myopia control important for long-term eye health?
Myopia control can reduce the risk of eye health problems later in life. By managing the rate at which the eyeball elongates, these treatments can help reduce the risk of developing sight-threatening conditions in adulthood, such as cataracts, glaucoma, and retinal detachment. Early intervention and regular monitoring can play a significant role in maintaining better eye health in the long run.
Call today to schedule your child’s eye exam today, and and learn how Stellest FDA authorized prescription lenses for myopia control can help.
*Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.